Brad Niles is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Aug 2020: Ariz Precision Medicine, Inc. (Davis, CA — pharmaceuticals — 2020; $685K reported sold to 10 investors).
What this means One deal on file with the SEC, filed Aug 2020. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Kevin Nagle (1 shared filing), Lokesh Sikaria (1 shared filing), Lonnie Bookbinder (1 shared filing) and Sabya Das (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Brad. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Brad Niles and found 2 differences, 1 worth asking the sponsor about: Form D filed 134 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.